Lv3
220 积分 2025-03-06 加入
Triad of Myasthenia Gravis, Myositis, and Myocarditis after Nivolumab Administration in a Patient with Cholangiocarcinoma
29天前
已完结
AB035. PD-1 checkpoint inhibitors exhibit significant antitumor activity in patients with Masaoka stage IV thymoma: a case report
29天前
已关闭
Immune checkpoint inhibitors in unresectable or metastatic thymic epithelial tumors – A real-world assessment of efficacy and toxicity
29天前
已关闭
Outcomes of immunotherapy in thymoma: A systematic review and meta-analysis
29天前
已关闭
Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study
29天前
已完结
Clinical Characteristics and Risk Factors of Immune Checkpoint Inhibitor‐Related Myocarditis: A Real World Observational Study
29天前
已完结
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
29天前
已完结
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
29天前
已完结
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors
29天前
已完结
Novel uses of complement inhibitors in myasthenia gravis—Two case reports
29天前
已完结
皖公网安备34019202002308
